Avalo Therapeutics Inc. Gains 81.13%
Wed, Sep 13, 2023 at 07:21 PM
Avalo Therapeutics Inc. (AVTX:NASDAQ) soared at $0.22, representing a gain of 81.1%. On Wed, Sep 13, 2023, AVTX:NASDAQ touched a New 2-Week High of $0.22. The stock got featured on our News Catalysts scanner on Tue, Sep 12, 2023 at 07:15 AM in the 'AGREEMENT' category. From Wed, Aug 30, 2023, the stock recorded 33.33% Up Days and 20.00% Green Days
The stock spiked on Wed, Sep 13, 2023 at $0.29 with a volume of 413M+.
About Avalo Therapeutics Inc. (AVTX:NASDAQ)
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in...
Top 10 Gainers:
- Avalo Therapeutics Inc. (AVTX:NASDAQ), 81.13%
- ZyVersa Therapeutics Inc Com Stk (ZVSA:NASDAQ), 47.86%
- Impel NeuroPharma Inc. (IMPL:NASDAQ), 44.98%
- BitNile Metaverse Inc Com (New) (BNMV:NASDAQ), 44.31%
- Rocket Pharmaceuticals, Inc. (RCKT:NASDAQ), 38.85%
- SRAX, Inc. (SRAX:NASDAQ), 33.33%
- DASAN Zhone Solutions, Inc. (DZSI:NASDAQ), 32.24%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 31.96%
- SHF Holdings Inc Cl A (SHFS:NASDAQ), 25.68%
- Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT), 25.13%